Shepherd Kaplan Krochuk’s Mateon Therapeutics, Inc. MATN Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio MATN Stock Details MATN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-151,250	Closed	-$94K	–	398
2016 Q3	$94K	Buy	151,250 +35,000	+30%	+$23.7K	0.02%	331
2016 Q2	$81K	Buy	+116,250	New	+$82.3K	0.02%	325

Other funds holding MATN

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Shepherd Kaplan Krochuk's MATN Position: Q4 2016 in Review

Shepherd Kaplan Krochuk sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 151,250 shares — an estimated $94K sold.

Shepherd Kaplan Krochuk first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $94K in Q3 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

Shepherd Kaplan Krochuk reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 151,250 Mateon Therapeutics, Inc. shares in Q4 2016, an estimated $94K.
Shepherd Kaplan Krochuk first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
Shepherd Kaplan Krochuk's Mateon Therapeutics, Inc. position peaked at $94K in Q3 2016.
1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2016, filed 10 Feb 2017.